Evaluation and Management of Tricuspid Murmurs
Echocardiography is the essential diagnostic tool for evaluating any tricuspid murmur, and management decisions hinge on distinguishing between primary (organic) and secondary (functional) tricuspid regurgitation, with surgical intervention primarily indicated when severe disease accompanies left-sided valve surgery or when severe isolated primary disease causes symptoms without severe right ventricular dysfunction. 1
Initial Evaluation Approach
Clinical Assessment
When evaluating a tricuspid murmur, focus on:
- Signs of right heart failure: peripheral edema, ascites, hepatomegaly, jugular venous distension
- Hepatic pressure maneuver: manual pressure below the liver can enhance the murmur of tricuspid regurgitation 2
- Carvallo sign: murmur intensity increases with inspiration
Echocardiographic Evaluation (The Gold Standard)
Echocardiography provides comprehensive assessment 3:
Structural evaluation:
- Distinguish primary (organic leaflet pathology) from secondary (functional) disease
- Identify specific etiologies: endocarditis vegetations, rheumatic leaflet retraction, carcinoid disease, flail leaflets from myxomatous or traumatic disease
- Measure tricuspid annular diameter (critical threshold: ≥40 mm or >21 mm/m²)
Severity grading parameters for TR:
- Proximal convergence zone (PISA radius ≥0.9 cm suggests severe)
- Proximal jet width and vena contracta (≥7 mm suggests severe)
- Inferior vena cava dilatation
- Hepatic vein systolic flow reversal
- Dense, triangular continuous wave Doppler jet 4
Associated findings:
- Right ventricular size and function (progressive RV dilatation is a key surgical trigger)
- Pulmonary artery systolic pressure via peak TR velocity
- Left-sided valve lesions (TR almost always accompanies left-sided disease in rheumatic cases)
MRI should be considered when echocardiographic assessment is suboptimal, particularly for RV size and function evaluation 3, 4
Management Algorithm
Tricuspid Regurgitation
Severe TR with Left-Sided Valve Surgery (Class I Indication)
Surgery is mandatory when severe TR exists in patients undergoing left-sided valve surgery 1. This is the most common scenario and represents the strongest indication.
Moderate TR with Left-Sided Valve Surgery (Class IIa)
Surgery should be strongly considered for:
Critical pitfall: Even mild-to-moderate secondary TR warrants intervention during left-sided surgery if the annulus is dilated, as TR tends to progress postoperatively 3, 6.
Isolated Severe Primary TR (Class I)
Surgery is indicated in symptomatic patients without severe RV dysfunction 1.
Key consideration: Delaying surgery risks irreversible RV damage and organ failure. The natural history shows poor prognosis even when functionally well-tolerated initially 3.
Isolated Severe Primary TR - Asymptomatic (Class IIa)
Surgery should be considered when there is:
- Progressive RV dilatation, OR
- Deteriorating RV function 1
Severe TR After Previous Left-Sided Surgery (Class IIa)
Reoperation should be considered in symptomatic patients with:
- No left-sided valve dysfunction
- No severe RV or LV dysfunction
- No severe pulmonary hypertension (systolic PA pressure <60 mmHg) 3, 6
Tricuspid Stenosis
Surgery is indicated (Class I) for:
- Symptomatic patients with severe TS 1
- Any patient with severe TS undergoing left-sided valve intervention 1
Percutaneous balloon valvuloplasty can be attempted in rare isolated TS cases with suitable anatomy, but frequently causes significant regurgitation with poor long-term data 3, 1
Surgical Considerations
Valve repair is strongly preferred over replacement 1:
- Ring annuloplasty with prosthetic rings is the first-line approach for secondary TR
- Valve replacement indicated when leaflets are significantly tethered or annulus severely dilated
- Biological prostheses preferred over mechanical valves due to high thrombosis risk in the tricuspid position 1
Medical Management
Diuretics are the mainstay for symptomatic relief but provide limited long-term efficacy 3, 1, 3:
- Loop diuretics for congestion
- Aldosterone antagonists may be beneficial 6
Guideline-directed medical therapy for heart failure should be optimized, particularly in secondary TR 6
Rhythm control in patients with chronic atrial fibrillation may help reduce secondary TR 6
Common Pitfalls to Avoid
- Underestimating secondary TR severity during left-sided valve surgery—even moderate disease with annular dilatation warrants intervention
- Delaying surgery in isolated severe primary TR—waiting for severe symptoms risks irreversible RV dysfunction
- Overlooking tricuspid stenosis—requires careful evaluation as it's often masked by dominant left-sided lesions 3, 1
- Inadequate echocardiographic assessment—must evaluate annular size, RV function, and pulmonary pressures, not just regurgitant jet
Emerging Therapies
Transcatheter tricuspid valve interventions may be considered in inoperable patients with symptomatic severe secondary TR at experienced heart valve centers, though data remain limited (Class IIb) 1, 6.